Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination

Cell Rep Med. 2023 Mar 21;4(3):100975. doi: 10.1016/j.xcrm.2023.100975. Epub 2023 Mar 14.

Abstract

Under the ever-present threat of a pandemic influenza strain, the evolution of a broadly reactive, neutralizing, functional, humoral immune response may hold the key to protection against both circulating and emerging influenza strains. We apply a systems approach to profile hemagglutinin- and neuraminidase-specific humoral signatures that track with the evolution of broad immunity in a cohort of vaccinated individuals and validate these findings in a second longitudinal cohort. Multivariate analysis reveals the presence of a unique pre-existing Fcγ-receptor-binding antibody profile in individuals that evolved broadly reactive hemagglutination inhibition activity (HAI), marked by the presence of elevated levels of pre-existing FCGR2B-binding antibodies. Moreover, vaccination with FCGR2B-binding antibody-opsonized influenza results in enhanced antibody titers and HAI activity in a murine model. Together, these data suggest that pre-existing FCGR2B binding antibodies are a key correlate of the evolution of broadly protective influenza-specific antibodies, providing insight for the design of next-generation influenza vaccines.

Keywords: FCGR2B; Fc receptor; antibody; hemagglutination inhibition; influenza; vaccine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Humans
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Mice
  • Vaccination

Substances

  • Antibodies, Neutralizing
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Influenza Vaccines
  • Antibodies, Viral